-
FDA approves new drug for children with ADHD
On March 2, the US FDA has approved a new drug application (NDA) for AZSTARYS (code name: KP415), once a day, for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older. Will be commercialized in the United States. To AZSTARYS is a compound capsule dosage f...Read more -
Looking ahead to the general trend of China’s pharmaceutical economy in 2021
In the overall pace of gradual recovery, some sub-sectors still have not recovered from the epidemic. From January to October, the revenue of the chemical preparation industry fell by 4.3% year-on-year, and profits fell by 9.3%. Nearly half of the net profits of related listed companies were loss...Read more -
The 2020 Nobel Prize in Physiology or Medicine is announced!
On October 5, according to the news published on the official website of the Nobel Prize, the 2020 Nobel Prize in Physiology or Medicine was jointly won by three scientists. According to reports, the three winners made groundbreaking discoveries, identified the hepatitis C virus, made blood testi...Read more
